Identification of molecular subtypes of glioblastoma by gene expression profiling (Q48332534)

10 February 2018

title

Identification of molecular subtypes of glioblastoma by gene expression profiling (English)

1 reference

10 February 2018

1 reference

9

Aarno Palotie

1 reference

10 February 2018

11

Timothy F Cloughesy

1 reference

10 February 2018

Steve Horvath

4

object named as

Steve Horvath

1 reference

10 February 2018

Stanley F Nelson

12

object named as

Stanley F Nelson

1 reference

10 February 2018

Gheeyoung Choe

6

object named as

Gheeyoung Choe

1 reference

10 February 2018

author name string

Paul S Mischel

1

1 reference

10 February 2018

Ruty Shai

2

1 reference

10 February 2018

Tao Shi

3

1 reference

10 February 2018

Kan V Lu

5

1 reference

10 February 2018

David Seligson

7

1 reference

10 February 2018

Thomas J Kremen

8

1 reference

10 February 2018

Linda M Liau

10

1 reference

10 February 2018

publication date

1 April 2003

1 reference

10 February 2018

language of work or name

0 references

1 reference

10 February 2018

volume

22

1 reference

10 February 2018

issue

15

1 reference

10 February 2018

page(s)

2361-2373

1 reference

10 February 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

EGFR overexpression and radiation response in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

The endothelin system in human glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Twelve amplified and expressed genes localized in a single domain in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

The biology of signal transduction inhibition: Basic science to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Clinical impact and functional aspects of tenascin-C expression during glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Progenitor cells and glioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

EGFRvIII as a promising target for antibody-based brain tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Enhanced degradation of EGF receptors by a sorting nexin, SNX1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Identification of novel mutations in MLC1 responsible for megalencephalic leukoencephalopathy with subcortical cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Role of fibronectin-stimulated tumor cell migration in glioma invasion in vivo: clinical significance of fibronectin and fibronectin receptor expressed in human glioma tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Rational therapeutic intervention in cancer: kinases as drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Bax Inhibitor-1, a Mammalian Apoptosis Suppressor Identified by Functional Screening in Yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

Epidermal growth factor receptor and Ink4a/Arf

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

inferred from DOI database lookup

7 January 2021

based on heuristic

Origin of oligodendrocytes within the human spinal cord

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206344

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1206344

1 reference

10 February 2018

Dimensions publication ID

1045257811

0 references

1 reference

10 February 2018